Karolinska Institute, Stockholm, Sweden 

Karolinska Institute (KI) is Sweden’s single largest centre of medical academic research and offers the country’s widest range of medical courses and programmes. As one of the world’s leading medical universities, KI is a one-faculty university dedicated solely to research and education in medical and health sciences, employing around 3,000 researchers. Ranked 11th in Europe and 39th in the world overall, KI is ranked 6th in Europe within the area “Clinical and Health” (THE World University Rankings 2021/22). 

KI is Imperial’s top co-publishing partner in Sweden, with 1,192 co-authored publications in the past 5 years (<50 authors). Imperial’s School of Public Health is working with the EU-funded CoroNAb project led by KI, in collaboration with Statens Serum and ETH Zurich, to identify multiple neutralising antibodies and nanobodies against coronavirus and to recommend where their use would be maximally effective. 

KI welcomes Imperial students in their medical elective courses during their research stays as space permits, and applicants must adhere to registration procedures and dates.  Many classes are taught in English.  

  • This Karolinska webpage is targeted to international staff and students that will stay at KI for a longer time but the links are also useful for short term visits. 

Additional webpages to support those preparing for a placement at Karolinksa :